Toronto, Ontario--(Newsfile Corp. - April 7, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) ('FSD Pharma' or the 'Company'), a biopharmaceutical company dedicated to building a...
TORONTO, ON / ACCESSWIRE / April 1, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ('FSD Pharma' or the 'Company'), a biopharmaceutical company dedicated to building a portfolio of...
TORONTO, ON / ACCESSWIRE / March 27, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ('FSD Pharma' or the 'Company'), a biopharmaceutical company dedicated to building a portfolio of...
TORONTO, ON / ACCESSWIRE / March 11, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ('FSD Pharma' or the 'Company'), a biopharmaceutical company dedicated to building a portfolio of...
TORONTO, ON / ACCESSWIRE / March 5, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ('FSD Pharma' or the 'Company'), a biopharmaceutical company dedicated to building a portfolio of...
TORONTO, ON / ACCESSWIRE / February 28, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ('FSD Pharma' or the 'Company'), a biopharmaceutical company dedicated to building a portfolio of...
HUGE Biopharma Australia, a subsidiary of biopharma company FSD Pharma Inc. (NASDAQ:HUGE), has agreed with clinical research organization Ingenu CRO to conduct a cross-over clinical study on a...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
TORONTO, ON / ACCESSWIRE / February 26, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ('FSD Pharma' or the 'Company'), a biopharmaceutical company dedicated to building a portfolio of...
TORONTO, ON / ACCESSWIRE / February 16, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ('FSD Pharma' or the 'Company'), a biopharmaceutical company dedicated to building a portfolio of...